US vaccine advisers to resume meeting with hepatitis B, COVID votes ahead

(Reuters) - U.S. vaccine advisers will reconvene on Friday for the second session of a key meeting to decide on hepatitis B and COVID-19 shots, after a tense opening day that highlighted divisions over the future of the country's immunization schedule. The group, which advises the Centers for Disease Control and Prevention on U.S. vaccination schedules, had been expected to vote Thursday on